Seven Eight Capital’s Halozyme HALO Stock Holding History

Seven Eight Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,481	Closed	-$312K	–	505
2022 Q4	$312K	Sell	5,481 -21,978	-80%	-$1.13M	0.08%	305
2022 Q3	$1.09M	Buy	27,459 +14,522	+112%	+$642K	0.22%	142
2022 Q2	$569K	Buy	+12,937	New	+$560K	0.23%	151
2021 Q4	–	Sell	-15,566	Closed	-$633K	–	556
2021 Q3	$633K	Buy	+15,566	New	+$651K	0.06%	390
2021 Q2	–	Sell	-4,739	Closed	-$202K	–	634
2021 Q1	$202K	Hold	4,739	–	–	0.05%	372
2020 Q4	$202K	Sell	4,739 -7,400	-61%	-$266K	0.05%	377
2020 Q3	$319K	Buy	12,139 +3,943	+48%	+$110K	0.07%	440
2020 Q2	$220K	Buy	+8,196	New	+$185K	0.16%	258
2015 Q4	–	Sell	-500	Closed	-$7K	–	599
2015 Q3	$7K	Buy	500 +400	+400%	+$8.03K	0.01%	464
2015 Q2	$2K	Buy	+100	New	+$1.76K	﹤0.01%	493

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Seven Eight Capital's HALO Position: Q1 2023 in Review

Seven Eight Capital sold out of Halozyme (HALO) in Q1 2023, closing a stake of 5,481 shares — an estimated $312K sold.

Seven Eight Capital first reported a position in HALO in Q2 2015 and held it in 10 quarters. The position peaked at $1.09M in Q3 2022. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

Seven Eight Capital reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
Seven Eight Capital sold 5,481 Halozyme shares in Q1 2023, an estimated $312K.
Seven Eight Capital first reported a position in Halozyme in Q2 2015 and held it in 10 quarters.
Seven Eight Capital's Halozyme position peaked at $1.09M in Q3 2022.
386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.